Drug details:
Molecular formula: C₃₆H₇₇N₇O₃^+₄

Standard name: [(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-[(E)-octadec-9-enoyl]amino]propylamino]-1-oxohexan-2-yl]azanium

Curated SMILES: CCCCCCCC/C=C/CCCCCCCC(=O)N(CCCNC(=O)[C@H](CCCC[NH3+])[NH3+])CCCNC(=O)[C@H](CCCC[NH3+])[NH3+]

Evidence for compound's anti-virulence activity:

Staphylococcus
Related VFcategory: Biofilm
Target: Not determined
Drug effect: Inhibits biofilm formation (membrane disruption might be a possible mechanism).
Max phase: Preclinical (in vitro)
Publication:
Konai MM, et al., 2015. Lysine-Based Small Molecules That Disrupt Biofilms and Kill both Actively Growing Planktonic and Nondividing Stationary Phase Bacteria. ACS Infect Dis 1(10):469-78.